Health
Breakthrough Study Reveals New Directions for CMV Vaccine Development to Protect Unborn Babies
2025-03-12
Author: Nur
Introduction
In a groundbreaking study by researchers from Weill Cornell Medicine and Oregon Health & Science University, new insights have emerged in the quest to develop an effective vaccine against cytomegalovirus (CMV), particularly focusing on preventing its transmission from mother to fetus during pregnancy. This research, published in the prestigious journal *Science Translational Medicine*, highlights the urgent need for novel vaccine targets to ensure better protection for newborns.
Brasil (PT)
Canada (EN)
Chile (ES)
Česko (CS)
대한민국 (KO)
España (ES)
France (FR)
Hong Kong (EN)
Italia (IT)
日本 (JA)
Magyarország (HU)
Norge (NO)
Polska (PL)
Schweiz (DE)
Singapore (EN)
Sverige (SV)
Suomi (FI)
Türkiye (TR)
الإمارات العربية المتحدة (AR)